RENX.L
Price:
$8.5
Market Cap:
$22.55M
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record systems to generate a unique patient risk score. Its products are used in kidney disease diagnosis and prognosis, clinical care, patient stratification for drug clinical trials, and drug target discovery. Renalytix AI plc has a license agreement with Mount Sinai Health System to develop and commercialize licensed products...[Read more]
Industry
Medical - Healthcare Information Services
IPO Date
2018-11-06
Stock Exchange
LSE
Ticker
RENX.L
According to Renalytix Plc’s latest financial reports and current stock price. The company's current PE Ratio is -0.71. This represents a change of -66.68% compared to the average of -2.13 of the last 4 quarters.
The mean historical PE Ratio of Renalytix Plc over the last ten years is -87.96. The current -0.71 PE Ratio has changed -19.28% with respect to the historical average. Over the past ten years (40 quarters), RENX.L's PE Ratio was at its highest in in the June 2019 quarter at 3.07. The PE Ratio was at its lowest in in the June 2018 quarter at -1147.04.
Average
-87.96
Median
-13.58
Minimum
-450.00
Maximum
-0.81
Discovering the peaks and valleys of Renalytix Plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 484.63%
Maximum Annual PE Ratio = -0.81
Minimum Annual Increase = -96.98%
Minimum Annual PE Ratio = -450.00
Year | PE Ratio | Change |
---|---|---|
2024 | -0.81 | -84.59% |
2023 | -5.26 | 43.08% |
2022 | -3.68 | -94.16% |
2021 | -62.98 | -20.69% |
2020 | -79.41 | 484.63% |
2019 | -13.58 | -96.98% |
The current PE Ratio of Renalytix Plc (RENX.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.25
5-year avg
-30.43
10-year avg
-87.96
Renalytix Plc’s PE Ratio is less than EKF Diagnostics Holdings plc (21.38), greater than MaxCyte, Inc. (-6.67), less than Gamma Communications plc (21.22), greater than Verici Dx plc (-1.42), less than Ergomed plc (44.78),
Company | PE Ratio | Market cap |
---|---|---|
21.38 | $102.09M | |
-6.67 | $220.54M | |
21.22 | $1.18B | |
-1.42 | $5.64M | |
44.78 | $771.71M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Renalytix Plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Renalytix Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Renalytix Plc's PE Ratio?
How is the PE Ratio calculated for Renalytix Plc (RENX.L)?
What is the highest PE Ratio for Renalytix Plc (RENX.L)?
What is the 3-year average PE Ratio for Renalytix Plc (RENX.L)?
What is the 5-year average PE Ratio for Renalytix Plc (RENX.L)?
How does the current PE Ratio for Renalytix Plc (RENX.L) compare to its historical average?